Inventor
David James MCMILLAN
Inventor
GB
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides22%
G01NInvestigating or analysing materials by determining their chemical or physical properties22%
C07BGeneral methods of organic chemistry6%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,545,720Anti-alpha-synuclein antibodies202612,473,355Gremlin-1 crystal structure and inhibitory antibody202512,410,244Anti-alpha-synuclein antibodies202511,807,680Gremlin-1 crystal structure and inhibitory antibody202311,732,034Tau-binding antibodies202311,292,831Anti-alpha synuclein antibodies202211,261,242Anti-alpha-synuclein antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UCB Biopharma SRL (7)· patent assignee history
2022–2026Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB Biopharma SRL | 7 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 7 | 2022–2026 |